EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective

Konrad Steinestel iD, Annette Arndt

Diagnostics · 05.03.2025 · 15 (5) · 631

DOI: 10.3390/diagnostics15050631 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 05.03.2025. Verfasst von Konrad Steinestel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, 89081 Ulm, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Advances in tissue-based biomarkers have significantly enhanced diagnostic and therapeutic approaches in NSCLC, enabling precision medicine strategies. This review provides a comprehensive analysis of the molecular pathologist’s practical approach to assessing NSCLC biomarkers across various specimen types (liquid biopsy, broncho–alveolar lavage, transbronchial biopsy/endobronchial ultrasound-guided biopsy, and surgical specimen), including challenges such as biological heterogeneity and preanalytical variability. We discuss the role of programmed death ligand 1 (PD-L1) immunohistochemistry in predicting immunotherapy response, the practice of histopathological tumor regression grading after neoadjuvant chemoimmunotherapy, and the application of DNA- and RNA-based techniques for detecting actionable molecular alterations. Finally, we emphasize the critical need for quality management to ensure the reliability and reproducibility of biomarker testing in NSCLC.

Schlagwörter

Stichwörter der Autor:innen

biomarkermolecular pathologynext-generation sequencingnon-small cell lung cancer

Autor:innen und Institutionen

  • Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, 89081 Ulm, Germany.

ORCID-Profile: Konrad Steinestel

Zitieren

APA

Steinestel, K., & Arndt, A. (2025). Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective. Diagnostics, 15(5), 631. https://doi.org/10.3390/diagnostics15050631

Vancouver

Steinestel K, Arndt A. Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective. Diagnostics. 2025;15(5):631. doi:10.3390/diagnostics15050631

BibTeX
@article{Steinestel2025,
  author = {Steinestel, Konrad and Arndt, Annette},
  title = {Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {631},
  doi = {10.3390/diagnostics15050631}
}
Kostenlos starten →